Header Logo

Connection

Mark Britton to Clinical Trials as Topic

Back to Details
This is a "connection" page, showing publications Mark Britton has written about Clinical Trials as Topic.
Mark Britton
Connection Strength
0.057
Clinical Trials as Topic
  1. Angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers for prevention and treatment of nephropathy associated with type 2 diabetes mellitus. Pharmacotherapy. 2005 Nov; 25(11):1602-20.
    View in: PubMed
    Score: 0.057
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.